Perioperative management of a patient with recently placed drug-eluting stents requiring urgent spinal surgery.

Journal of General Internal Medicine
Eira RothMichael Elnicki

Abstract

Patients receiving drug-eluting coronary stents (DES) require antiplatelet therapy for at least 12 months to prevent stent thrombosis (ST), a potentially calamitous event. Since interruption of antiplatelet therapy is the greatest risk factor for ST, it is imperative that the decision to discontinue these agents be based on an accurate assessment of the patient's risk for bleeding complications. Individuals who are regarded as being at a high risk are those undergoing intracranial, spinal or intraocular surgeries. These patients require alternative agents during the perioperative period to minimize both their risk of perioperative thrombosis and intraoperative hemorrhage. We report the case of a woman who required spinal surgery 3 months after she underwent placement of two drug-eluting stents. The patient's clopidogrel was stopped 5 days prior to surgery and an infusion of eptifibatide was used to "bridge" antiplatelet therapy during the perioperative period. Postoperatively, anticoagulation therapy was reinstituted using aspirin with clopidogrel. This case serves as a successful example of bridging therapy using a short acting and gycoprotein (GP) IIb/IIIa inhibitor as a means of maintaining antiplatelet therapy during the pe...Continue Reading

References

Aug 18, 1997·The American Journal of Cardiology·D R Phillips, R M Scarborough
Apr 12, 2000·Journal of the American College of Cardiology·G L KałuzaA E Raizner
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
May 23, 2002·Cleveland Clinic Journal of Medicine·Gregory P Gerschutz, Deepak L Bhatt
Mar 26, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Dominick Joseph AngiolilloCarlos Macaya
Jul 24, 2003·Journal of the American College of Cardiology·Stephanie H WilsonPeter B Berger
Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Thomas Lecompte, Jean-François Hardy
May 15, 2007·Journal of Cardiovascular Pharmacology and Therapeutics·Cornelius M DykeMichael R Tamberella
Jun 14, 2008·The American Journal of Cardiology·Bryan P YanUNKNOWN Melbourne Interventional Group
Jul 18, 2008·Anesthesia and Analgesia·Lisa T NewsomeRoger L Royster
Mar 10, 2009·The American Journal of Cardiology·Probal RoyRon Waksman
Jun 16, 2009·International Journal of Cardiology·Eduardo L Tin-HayHuay-Cheem Tan
Feb 23, 2010·JACC. Cardiovascular Interventions·Ali O Abualsaud, Mark J Eisenberg

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Jeffrey D WesslerRobert P Giugliano
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Khoi D ThanB Gregory Thompson
The Journal of Laryngology and Otology
D C Sylvester, A P Coatesworth
© 2022 Meta ULC. All rights reserved